- Home
- SLS vs ELVA Comparison
SLS vs ELVA Comparison
Compare SLS & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- ELVA
- Stock Information
- Founded
- SLS 2012
- ELVA 1996
- Country
- SLS United States
- ELVA Canada
- Employees
- SLS N/A
- ELVA N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- ELVA
- Sector
- SLS Health Care
- ELVA
- Exchange
- SLS Nasdaq
- ELVA Nasdaq
- Market Cap
- SLS 75.3M
- ELVA 71.0M
- IPO Year
- SLS N/A
- ELVA N/A
- Fundamental
- Price
- SLS $1.32
- ELVA $2.31
- Analyst Decision
- SLS Buy
- ELVA Strong Buy
- Analyst Count
- SLS 1
- ELVA 4
- Target Price
- SLS $3.00
- ELVA $8.75
- AVG Volume (30 Days)
- SLS 753.9K
- ELVA 32.7K
- Earning Date
- SLS 11-13-2024
- ELVA 12-31-2024
- Dividend Yield
- SLS N/A
- ELVA N/A
- EPS Growth
- SLS N/A
- ELVA N/A
- EPS
- SLS N/A
- ELVA 0.02
- Revenue
- SLS N/A
- ELVA $49,490,000.00
- Revenue This Year
- SLS N/A
- ELVA $4.36
- Revenue Next Year
- SLS N/A
- ELVA $80.25
- P/E Ratio
- SLS N/A
- ELVA $133.94
- Revenue Growth
- SLS N/A
- ELVA 45.33
- 52 Week Low
- SLS $0.50
- ELVA $1.67
- 52 Week High
- SLS $1.72
- ELVA $4.58
- Technical
- Relative Strength Index (RSI)
- SLS 60.02
- ELVA 57.26
- Support Level
- SLS $1.22
- ELVA $2.06
- Resistance Level
- SLS $1.39
- ELVA $2.74
- Average True Range (ATR)
- SLS 0.08
- ELVA 0.21
- MACD
- SLS 0.02
- ELVA 0.02
- Stochastic Oscillator
- SLS 72.00
- ELVA 57.43
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and industry leading battery longevity. Geographically it earns key revenue from the United States.